Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: fast-tracker who wrote (1597)	3/26/1998 1:41:00 PM
From: Geoff Krone	Respond to of 8117

Good job, fast-tracker! I think the "CPR" question can certainly be laid to rest. There is a related issue which I don't think poses a problem, but does not seem to be addressed on the company's website: Does the use of a defibrillator pose any special problems? Compared with an I.V. line in the arm, the F.A.S.T.1 application site is much closer to the points at which the "paddles" are applied. Part of the electrical charge will travel through the saline solution in the tube and up to the bag. I believe that the tube and bag are non-conducting, so there should be no hazard to someone in contact with them. Since defibrillators apparently work about the same way on people of varying sizes, I assume that the presence of an extra liter of saline does not affect the performance characteristics of the defibrillator (any more than the presence of an extra liter of body tissue would.) But it would be nice to have this confirmed by someone with extensive knowledge. Maybe someone can ask this at the show, if it's not too late. As to infection rates, I'm not sure about the applicability of the existing literature to this question, because the techniques and circumstances are so different. Some differences probably imply less of a problem with the F.A.S.T.1 than with previous applications, and some more. I'd guess that previous IO techniques might be more invasive, and almost certainly have usually been performed in a hospital. In a hospital, it should theoretically be easier to ensure that the patient's skin is free of germs which might be carried in by the needle. OTOH, any hospital germs that DO get in are more likely to be antibiotic-resistant. If the patient's skin was clean when the F.A.S.T.1 was applied, it looks as though the protective dome would do an excellent job of protecting the site from then on, probably better than whatever wound dressing has been used with previous IO methods. Overall, I strongly doubt that risk of infection will be much of a hindrance to use of the F.A.S.T.1. Best regards, Geoff

To: fast-tracker who wrote (1597)	3/26/1998 1:46:00 PM
From: the Chief	Read Replies (2) \| Respond to of 8117

Hi fastracker. Excellent piece of DD, thanks for your effort! Just shows me that as I get older the more I forget, I read the web-site too, but those brain cells died about 4 days later. The stock is coming back just fine, buyers building again. Its at $5.45 right now. I think we'll end up flat for the day. Shouldn't be a problem recovering the last .30c Hi GBM. Still waiting to find out where you got that market depth report this morning!! the Chief